These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1026 related items for PubMed ID: 20334417

  • 1. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M, Selegård L, Klasson A, Söderlind F, Abrikossova N, Skoglund C, Bengtsson T, Engström M, Käll PO, Uvdal K.
    Langmuir; 2010 Apr 20; 26(8):5753-62. PubMed ID: 20334417
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
    Xu ZP, Kurniawan ND, Bartlett PF, Lu GQ.
    Chemistry; 2007 Apr 20; 13(10):2824-30. PubMed ID: 17186555
    [Abstract] [Full Text] [Related]

  • 3. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z, Yu D, Liu C, Yang X, Zhang N, Ma C, Song J, Lu Z.
    J Drug Target; 2011 Sep 20; 19(8):657-65. PubMed ID: 21091273
    [Abstract] [Full Text] [Related]

  • 4. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD, Chang CC, Thamm DH, Kraft SL, Harmon JF, Vogt AP, Sumerlin BS, Boyes SG.
    Langmuir; 2009 Aug 18; 25(16):9487-99. PubMed ID: 19422256
    [Abstract] [Full Text] [Related]

  • 5. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    Park JY, Baek MJ, Choi ES, Woo S, Kim JH, Kim TJ, Jung JC, Chae KS, Chang Y, Lee GH.
    ACS Nano; 2009 Nov 24; 3(11):3663-9. PubMed ID: 19835389
    [Abstract] [Full Text] [Related]

  • 6. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
    Fu Y, Raatschen HJ, Nitecki DE, Wendland MF, Novikov V, Fournier LS, Cyran C, Rogut V, Shames DM, Brasch RC.
    Biomacromolecules; 2007 May 24; 8(5):1519-29. PubMed ID: 17402781
    [Abstract] [Full Text] [Related]

  • 7. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
    Faucher L, Tremblay M, Lagueux J, Gossuin Y, Fortin MA.
    ACS Appl Mater Interfaces; 2012 Sep 26; 4(9):4506-15. PubMed ID: 22834680
    [Abstract] [Full Text] [Related]

  • 8. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
    Burai L, Tóth E, Sour A, Merbach AE.
    Inorg Chem; 2005 May 16; 44(10):3561-8. PubMed ID: 15877439
    [Abstract] [Full Text] [Related]

  • 9. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S, Ruloff R, Tóth E, Merbach AE.
    Chemistry; 2003 Aug 04; 9(15):3555-66. PubMed ID: 12898682
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X, Jackson EF, Price RE, Kim EE, Wu Q, Wallace S, Charnsangavej C, Gelovani JG, Li C.
    Bioconjug Chem; 2004 Aug 04; 15(6):1408-15. PubMed ID: 15546209
    [Abstract] [Full Text] [Related]

  • 11. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
    Riyahi-Alam N, Behrouzkia Z, Seifalian A, Haghgoo Jahromi S.
    Biol Trace Elem Res; 2010 Dec 04; 137(3):324-34. PubMed ID: 20049554
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
    Livramento JB, Helm L, Sour A, O'Neil C, Merbach AE, Tóth E.
    Dalton Trans; 2008 Mar 07; (9):1195-202. PubMed ID: 18283380
    [Abstract] [Full Text] [Related]

  • 15. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.
    Hu F, Jia Q, Li Y, Gao M.
    Nanotechnology; 2011 Jun 17; 22(24):245604. PubMed ID: 21508500
    [Abstract] [Full Text] [Related]

  • 16. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y, Ji L, Zhang B, Yin P, Qiu Y, Song D, Zhou J, Li Q.
    Nanotechnology; 2013 May 03; 24(17):175101. PubMed ID: 23558298
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H, Zhuang Y, Sun Y, Dai A, Shi X, Wu D, Li F, Hu H, Yang S.
    Biomaterials; 2011 Jul 03; 32(20):4584-93. PubMed ID: 21458063
    [Abstract] [Full Text] [Related]

  • 19. Gd-functionalised Au nanoparticles as targeted contrast agents in MRI: relaxivity enhancement by polyelectrolyte coating.
    Warsi MF, Adams RW, Duckett SB, Chechik V.
    Chem Commun (Camb); 2010 Jan 21; 46(3):451-3. PubMed ID: 20066322
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.